1994
DOI: 10.1016/s0944-7113(11)80062-0
|View full text |Cite
|
Sign up to set email alerts
|

Does garlic alter the lipid pattern in normal volunteers?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
1
2

Year Published

1995
1995
2013
2013

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(27 citation statements)
references
References 5 publications
1
23
1
2
Order By: Relevance
“…Similarly, one study conducted by Mader [20] in 1990 among patients suffering from dyslipidemia over a period of 16 weeks using 800 mg of garlic (standardized to 1.3% of Alliin) showed 12% reduction in serum cholestrol levels and 17% reduction in triglyceride levels in comparison to placebo; however, it was also noticed that the greatest cholesterol-lowering effects were seen in patients with initial total cholesterol values between 250 and 300 mg/dL. The results of this trial were somewhat contradicted by findings of a trial by Saradeth et al [26] where 600 mg of dried garlic powder (Kwai, Lichwer standardized to 1.3% alliin) was given to healthy patients with normal lipid levels over a period of 10 weeks. There was a significant reduction in total cholestrol and triglycerides levels confirming the fact that it can induce changes in blood lipids, even if these variables had been normal to start with Similarly another trial by Gadkari and Joshi on healthy medical students after consumption of 10 gm raw garlic showed significant reduction in serum cholesterol and increase in clotting time and fibrinolytic activity [27].…”
Section: Garlic Role In Dyslipidemiacontrasting
confidence: 60%
“…Similarly, one study conducted by Mader [20] in 1990 among patients suffering from dyslipidemia over a period of 16 weeks using 800 mg of garlic (standardized to 1.3% of Alliin) showed 12% reduction in serum cholestrol levels and 17% reduction in triglyceride levels in comparison to placebo; however, it was also noticed that the greatest cholesterol-lowering effects were seen in patients with initial total cholesterol values between 250 and 300 mg/dL. The results of this trial were somewhat contradicted by findings of a trial by Saradeth et al [26] where 600 mg of dried garlic powder (Kwai, Lichwer standardized to 1.3% alliin) was given to healthy patients with normal lipid levels over a period of 10 weeks. There was a significant reduction in total cholestrol and triglycerides levels confirming the fact that it can induce changes in blood lipids, even if these variables had been normal to start with Similarly another trial by Gadkari and Joshi on healthy medical students after consumption of 10 gm raw garlic showed significant reduction in serum cholesterol and increase in clotting time and fibrinolytic activity [27].…”
Section: Garlic Role In Dyslipidemiacontrasting
confidence: 60%
“…A total of 63 publications were assessed for eligibility (Figure ). A total of 39 trials fit inclusion criteria for meta‐analysis, of which 37 reported sufficient data on total cholesterol levels, 26 reported LDL cholesterol data, 30 reported HDL cholesterol data, and 32 reported triglyceride data (Table ) …”
Section: Resultsmentioning
confidence: 99%
“…87 The cholesterol-lowering properties of garlic have been linked to the inhibition of cholesterol synthesis 88,89 and the suppression of LDL oxidation. 90 A variety of Study Bordia (1981) 25 Sitprija et al (1987) 28 Plengvidhya et al (1988) 29 Vorberg & Schneider (1990) 32 Mader (1990) 31 Auer et al (1990) 30 Rotzsch et al (1992) 34 Phelps & Harris (1993) 37 DeASantos & Gruenwald (1993) 38 Jain et al (1993) 35 Saradeth et al (1994) 39 Simons et al (1995) 40 Neil et al (1996) 41 Adler & Holub (1997) 42 Bordia et al (1998) 45 Isaacsohn et al (1998) 46 Berthold et al (1998) 44 organosulfur components in garlic preparations may, to different degrees, exert cardiovascular effects/benefits. S-allylcysteine (commonly known by its abbreviation SAC) has been identified as the active and stable component in aged garlic extract, allowing standardization of preparations by S-allylcysteine dosage, but the active component in garlic powder is less well established, as the commonly named allicin, an alliin derivate, is volatile and is likely only transiently responsible for the cardiovascular effects.…”
Section: Discussionmentioning
confidence: 99%
“…The studies by Williams et al ,52 Mader,10 Macan et al 14 and Kiesewetter et al 50 were included in the study by Reinhart et al , but were excluded in the current study, as these studies enrolled subjects suffering from diabetes mellitus,10, 50 taking lipid‐lowering drugs,50, 52 or gender difference between the garlic and placebo groups 14. We also added three studies23, 24, 42 omitted in Reinhart's review, but did not include four studies45, 46, 57, 58 due to incomplete data for statistical pooling. In addition, this study analyzed the effects of garlic on Apo‐B and TC/HDL‐C ratio.…”
Section: Discussionmentioning
confidence: 99%